Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study

Introduction: Acute lung injury is associated with dysfunctional immune response to SARS-CoV-2. This leads to CRS, which require immunomodulatory treatments aiming to limit the excessive production of cytokines. The literature so far indicates the effectiveness of tocilizumab in patients with COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chober, Daniel, Aksak-Wąs, Bogusz, Bobrek-Lesiakowska, Katarzyna, Budny-Finster, Anna, Hołda, Ewa, Mieżyńska-Kurtycz, Joanna, Jamro, Grzegorz, Parczewski, Miłosz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101084/
https://www.ncbi.nlm.nih.gov/pubmed/35566412
http://dx.doi.org/10.3390/jcm11092286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101084/
https://www.ncbi.nlm.nih.gov/pubmed/35566412
http://dx.doi.org/10.3390/jcm11092286

Ejemplares similares